Skip to main content
. Author manuscript; available in PMC: 2015 Oct 28.
Published in final edited form as: Cancer Lett. 2014 Jul 25;353(2):272–280. doi: 10.1016/j.canlet.2014.07.033

Fig. 1.

Fig. 1

Growth curves of GL261 tumors that were untreated, or were given 1, 2, or 3 CPA injections on the CPA/6d schedule. Data shown are tumor volumes normalized to 100% on the first day of drug treatment (=day 0), mean ± SEM, for n = 6-8 tumors/group, except for 1 cycle CPA, where n=4. Arrows at bottom indicate days of CPA treatment at 140 mg/kg-BW. The measured tumor volumes on day 0 were 685 ± 55 mm3, 785 ± 370 mm3, 715 ± 105 mm3 (mean ± SEM) for the groups given 1, 2, and 3 CPA injections, respectively.